<DOC>
	<DOCNO>NCT00463476</DOCNO>
	<brief_summary>Japanese encephalitis virus lead cause viral neurological disease disability Asia . The severity sequela , together volume case , make JE important cause viral encephalitis world . Approximately 3 billion people—including 700 million children—live area risk Asia JE . JE commonly infect child age 1 15 year , also infect adult area virus newly introduce . More 50,000 case report annually cause estimate 10,000 15,000 death . This figure believe represent small proportion disease burden actually exist . An inactivated JE vaccine currently use Sri Lanka . It give child 3 dos , 12 month age , 13 month age , 2 year age . A booster dose must also give child 5 year age . If Sri Lanka decide replace inactivated JE vaccine live attenuate JE vaccine , many child still need 3rd booster dose inactivate JE vaccine . This research study do see live attenuate vaccine work well replace inactivated JE vaccine safe Sri Lankan child .</brief_summary>
	<brief_title>Boosterability Live Attenuated Japanese Encephalitis ( JE ) Vaccine Children Who Have Previously Received Inactivated JE Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy child 2 year ( ±3 month ) 5 year ( ±3 month ) age enrollment visit . Subject fullterm infant . Subject 's parent legal guardian literate willing provide write informed consent . Subject uptodate vaccination recommend Sri Lankan childhood immunization schedule . Enrolled another clinical trial involve therapy . Subject and/or parent ( ) guardian ( ) unable attend schedule visit comply study procedure . Received nonstudy vaccine within 2 week prior enrolment refusal postpone receipt vaccine 28 day study entry . Prior anticipate receipt immune globulin blood product , injected oral corticosteroid immune modulator therapy except routine vaccine within 6 week administration study vaccine . Individuals taper dose schedule oral steroid last &lt; 7 day may include trial long receive one course within last 2 week prior enrolment . History document suspected encephalitis , encephalopathy , meningitis . History measles . History Japanese encephalitis . Serious adverse event relate ( i.e. , possible , probably , definite ) previous receipt JE vaccine , applicable . Persistent inconsolable cry ( &gt; 3 hour ) observe previous receipt JE vaccine , applicable . Hypotonic hyporesponsiveness past receipt JE vaccine , applicable . Suspected known hypersensitivity investigational market vaccine component . History serious chronic disease ( cardiac , renal , neurologic , metabolic , rheumatologic ) . Underlying medical condition inborn error metabolism , failure thrive , bronchopulmonary dysplasia , major congenital abnormality require surgery chronic treatment . History thrombocytopenic purpura . History seizure , include history febrile seizure , neurologic disorder . Known suspected immunologic function impairment kind and/or know HIV infection . Parent know suspected immunologic function impairment kind and/or know HIV infection . Any condition , opinion investigator , would pose health risk participant interfere evaluation study objective .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>